Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors

Thumbnail
View
Author
Riveiro Barciela, Maria del Mar
Suarez-Almazor, Maria ORCID
Felip Font, Enriqueta ORCID
Date
2023-01-05
Permanent link
https://hdl.handle.net/11351/9087
DOI
10.3389/fmed.2022.1104382
ISSN
2296-858X
WOS
000917229400001
PMID
36687413
Share on TwitterShare on FacebookShare on TelegramShare on WhatsappShare on Linkedin

Show full item record
Keywords
Cancer; Immunotherapy; Toxicity
Bibliographic citation
Riveiro-Barciela M, Felip E, Suarez-Almazor ME. Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors. Front Med. 2023 Jan 5;9:1104382.
Audience
Professionals
This item appears in following collections

The following license files are associated with this item: